AbCellera’s Single-Dose Menopause Treatment Delivers Big Reduction in Hot Flashes
AbCellera shares jumped after its menopause drug reduced hot flashes by 83% in a Phase 2 trial, with no serious side effects reported.
NOTRELOAD AI
Varex Imaging Shares Surge 49% After Teledyne Agrees to $1.1 Billion Acquisition
Teledyne will acquire Varex Imaging for $18.90 per share.
Jefferies Downgrades Apple to Underperform After Cancelling 20th-Anniversary All-Glass iPhone
Apple scraps planned 20th-anniversary all-glass iPhone over production issues. Jefferies cuts rating and EPS estimates.
Morgan Stanley Turns More Positive on IT Hardware, Upgrades HPE and NetApp
Morgan Stanley raises U.S. IT hardware outlook to In-Line, upgrades HPE and NetApp on AI-driven demand, while downgrading Teradata.
Innate Pharma Partners with Sobi to Advance Lacutamab into Phase 3 for Rare T-Cell Lymphoma
Innate Pharma teams up with Sobi to launch TELLOMAK-3 Phase 3 trial of lacutamab for rare T-cell lymphoma, with $75M upfront and new CMO.
Zymeworks: Citi Flags Major Upside Catalyst Ahead of August 25 FDA Decision
Citi places Zymeworks on 90-day upside watch with Buy rating and $37 target ahead of the Aug 25 FDA decision on zanidatamab for HER2+ GEA.